<DOC>
	<DOCNO>NCT00233766</DOCNO>
	<brief_summary>The objective study assess performance safety two reduce sirolimus dos Bx VELOCITY Balloon-Expandable stent , mount Raptor√¢ rapid exchange ( RX ) Stent Delivery System ( SDS ) patient de novo native coronary artery lesion .</brief_summary>
	<brief_title>Evaluation Two Reduced Sirolimus Doses Treatment de Novo Coronary Artery Lesions ( REDOX )</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1 . Male nonpregnant female patient minimum 18 year age 2 . No significant ( &gt; 50 % ) untreated stenosis proximal distal target lesion treat procedure may require revascularization impede runoff ; 3 . Target lesion 18mm length ( visual estimate ) ; 4 . Target lesion 3.0mm 3.5mm diameter ( visual estimate ) ; 5 . Target lesion stenosis &gt; 50 % &lt; 100 % ( visual estimate ) ; 1 . A Qwave nonQwave myocardial infarction within precede 72 hour unless CK CKMB enzymes back normal ; 2 . Ejection fraction 30 % ; 3 . Stent placement target lesion cover side branch &gt; 2.0mm diameter ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>